Found 21 results
Filters: Author is O'Dell, Sijy  [Clear All Filters]
Feng Y, McKee K, Tran K, O'Dell S, Schmidt SD, Phogat A, Forsell MN, Karlsson Hedestam GB, Mascola JR, Wyatt RT.  2012.  Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.. J Biol Chem. 287(8):5673-86.
Dosenovic P, Soldemo M, Scholz JL, O'Dell S, Grasset EK, Pelletier N, Karlsson MCI, Mascola JR, Wyatt RT, Cancro MP et al..  2012.  BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses.. J Immunol. 188(12):6018-26.
Sundling C, Li Y, Huynh N, Poulsen C, Wilson R, O'Dell S, Feng Y, Mascola JR, Wyatt RT, Karlsson Hedestam GB.  2012.  High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.. Sci Transl Med. 4(142):142ra96.
Li Y, O'Dell S, Wilson R, Wu X, Schmidt SD, Hogerkorp C-M, Louder MK, Longo NS, Poulsen C, Guenaga J et al..  2012.  HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins.. J Virol. 86(20):11231-41.
Wu X, Wang C, O'Dell S, Li Y, Keele BF, Yang Z, Imamichi H, Doria-Rose NA, Hoxie JA, Connors M et al..  2012.  Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.. J Virol. 86(10):5844-56.
Doria-Rose NA, Georgiev I, O'Dell S, Chuang G-Y, Staupe RP, McLellan JS, Gorman J, Pancera M, Bonsignori M, Haynes BF et al..  2012.  A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies.. J Virol. 86(15):8319-23.